Published by
@ShahidNShah
@ShahidNShah
March 19 to March 21, 2024
Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, Massachusetts, 02114, United States
The 4th Wet AMD and Diabetic Eye Disease Drug Development Summit returns to Boston this March, gathering over 70 industry-based retinal vascular experts from renowned companies like Bayer, Boehringer Ingelheim, Genentech, Novartis, and OcuTerra. This dedicated forum aims to revolutionize the treatment of chronic, sight-threatening retinal vascular diseases, enhancing patient outcomes. The 2024 event features new contributors such as Aviceda Therapeutics, Adverum Biotechnologies, and others, presenting compelling content on novel targets, retinal imaging, clinical biomarkers, and innovative modalities for retinal and choroidal neovascularization. Scheduled from Tue, March 19, 2024, at 08:00 to Thu, March 21, 2024, at 15:00.
[Read on wet-amd-drug-development.com](https://wet-amd-drug-development.com/)
Continue reading at et-amd-drug-development.com
March 19 to March 21, 2024
Holiday Inn London - Kensington High St., an IHG Hotel, Wrights Lane, London, England, W8 5SP, United Kingdom
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Oct 29, 2024 at 9:41am